Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Deloitte
Julphar
Queensland Health
Chinese Patent Office
Harvard Business School
Medtronic
Covington
Cerilliant
Citi

Generated: August 19, 2017

DrugPatentWatch Database Preview

ACYCLOVIR SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Acyclovir Sodium, and when can generic versions of Acyclovir Sodium launch?

Acyclovir Sodium is a drug marketed by Aurobindo Pharma Ltd, Zydus Pharms Usa Inc, Eurohlth Intl Sarl, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Parenteral, Hikma Pharms Llc, Athenex Inc, and Apothecon. and is included in fifteen NDAs.

The generic ingredient in ACYCLOVIR SODIUM is acyclovir sodium. There are fifty-five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.

Summary for Tradename: ACYCLOVIR SODIUM

Patents:0
Applicants:10
NDAs:15
Suppliers / Packagers: see list7
Bulk Api Vendors: see list148
Clinical Trials: see list2,461
Patent Applications: see list6,031
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ACYCLOVIR SODIUM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION203701-001Oct 11, 2013APRXNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074969-001Aug 26, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074897-001Feb 27, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074720-001Apr 22, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Eurohlth Intl Sarl
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074913-002Oct 15, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Cerilliant
Dow
Healthtrust
Covington
Colorcon
Chubb
Daiichi Sankyo
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot